Director, Precision Medicine, Oncology
- Employer
- Regeneron Pharmaceuticals, Inc.
- Location
- Tarrytown, NY, United States
- Start date
- Oct 24, 2020
View more
- Discipline
- Clinical, Clinical Trials, Science/R&D
- Required Education
- Doctorate/PHD/MD
- Position Type
- Full time
- Hotbed
- Pharm Country, Best Places to Work
Job Details
A TYPICAL DAY MAY INCLUDE
- Developing Precision Medicine and clinical translational research strategy within the Immune-Oncology clinical development programs
- Generating appropriate sections of project planning documents and clinical trial protocols to outline, provide justification and enable execution of the Precision Medicine strategy
- Collaborating with the (internal and external) matrix team environment to design, develop, execute and interpret the biomarker assay analyses needed to complete the clinical development program objectives.
Generating data presentation materials, including the internal development program reviews, external conference presentations and peer reviewed manuscripts.
Reviewing sections of the patient Informed Consent Forms and provides scientific expertise pertaining to clinical sample acquisition, including tumor and germline DNA for genomic sequencing studies.
Reviewing external clinical laboratory bids to ensure they are consistent with the clinical protocol, budget and other development program needs.
Representing Precision Medicine in internal clinical development and research team meetings, external scientific, advisory boards, regulatory agency and investigator meetings.
THIS MAY BE FOR YOU IF:
- You like to drive, manage, execute and deliver results for sophisticated objectives
- You can balance operating independently while collaborating in a highly matrixed and team-based environment
- You have experience being a link between research and clinical teams
- You want to realize the impact of your work on patients
EXPERIENCE
To be considered for this position you must have a Ph.D., M.D., or equivalent degree with post-doctoral experience with at least 10 years of pharmaceutical proven experience along with designing and execution of clinical biomarker studies. Working knowledge of clinical protocol and regulatory document development is required. Experience in immuno-oncology or oncology development would be preferred. Knowledge of molecular and cellular biomarker technology platforms, including next generation sequencing, highly multiplex single cell and tissue expression analysis, and computational biology approaches would be expected
Does this sound like you? Apply now to take your first steps toward living the Regeneron Way! We have an inclusive and diverse culture that provides amazing benefits including health and wellness programs, fitness centers and stock for employees at all levels!
Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, nationality, national or ethnic origin, civil status, age, citizenship status, membership of the Traveler community, sexual orientation, disability, genetic information, familial status, marital or registered civil partnership status, pregnancy or maternity status, gender identity, gender reassignment, military or veteran status, or any other protected characteristic in accordance with applicable laws and regulations. We will ensure that individuals with disabilities are provided reasonable accommodations to participate in the job application process. Please contact us to discuss any accommodations you think you may need.
SKC, #LI-SC1, biomarker strategy, clinical development, oncology, immuno-onco
Company
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
Stock Symbol: REGN
Stock Exchange: NASDAQ
- Website
- https://www.regeneron.com/
- Phone
- 914-847-7000
- Location
-
Corporate Headquarters
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert